Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) have been given an average rating of "Buy" by the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $8.63.

BIOX has been the topic of several research analyst reports. Canaccord Genuity Group lowered their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a report on Thursday, February 13th. Oppenheimer lowered their price target on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a report on Tuesday, April 22nd. Finally, Lake Street Capital lowered their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a report on Friday, February 7th.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of large investors have recently bought and sold shares of BIOX. Jones Financial Companies Lllp boosted its holdings in Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after acquiring an additional 5,339 shares during the period. Bank of America Corp DE boosted its holdings in Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after acquiring an additional 3,735 shares during the period. Jump Financial LLC bought a new stake in Bioceres Crop Solutions during the fourth quarter valued at about $72,000. Northern Trust Corp bought a new stake in Bioceres Crop Solutions during the fourth quarter valued at about $93,000. Finally, Avanza Fonder AB bought a new stake in Bioceres Crop Solutions during the first quarter valued at about $72,000. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Stock Up 2.2%

NASDAQ:BIOX traded up $0.10 during trading hours on Monday, hitting $4.63. 233,621 shares of the stock traded hands, compared to its average volume of 173,102. The firm has a 50 day moving average price of $4.35 and a 200 day moving average price of $5.47. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a fifty-two week low of $3.51 and a fifty-two week high of $11.86. The firm has a market cap of $290.35 million, a price-to-earnings ratio of 231.62 and a beta of 0.40.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.08. Bioceres Crop Solutions had a net margin of 0.58% and a return on equity of 0.68%. The business had revenue of $59.60 million for the quarter, compared to analysts' expectations of $61.80 million. Equities research analysts anticipate that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.